SectorHealthcare Equipment and Supplies
Established Date07/11/2006
Listing Date17/04/2019
ExchangeNASDAQ Stock Exchange
Full-time Employees120
Fiscal Year Ends31/12
Security TypeDepository Receipts (Ordinary Shares)
Office address16 Hartum Street, RAD Tower, 14th Floor, Har HaHotzvim, Jerusalem, 9777516, Israel
BusinessFocus on the development and sale of non-invasive neuromodulation products.
IntroductionBrainsway Ltd., was incorporated under the laws of the State of Israel on November 7, 2006. The company is a global leader in advanced non-invasive neurostimulation for the treatment of mental health disorders. The company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. The company is committed to leading through superior science and building on what is considered to be unparalleled clinical evidence. The company is the first and only TMS company to receive U.S. Food and Drug Administration (FDA) approval for three separate mental health disorder indications based on clinically proven efficacy, as demonstrated in a pivotal randomized placebo-controlled study. Current indications include major depression (MDD) (including the reduction of comorbid anxiety symptoms, commonly referred to as anxiety depression), obsessive-compulsive disorder (OCD), and smoking addiction.
